Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Barraud, Nicolas ^a   Buson, Alberto ^b   Jarolimek, Wolfgang ^b   Rice, Scott A ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Pharmaxis Ltd   (Australia)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MANNITOL; SODIUM CHLORIDE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSMOLARITY; OSMOTIC STRESS; PHARMACOLOGICAL BLOCKING; PHENOTYPE; PROTON MOTIVE FORCE; PSEUDOMONAS AERUGINOSA; REVERTANT; SENSITIVITY ANALYSIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; DIURETICS, OSMOTIC; DRUG RESISTANCE, BACTERIAL; HUMANS; MANNITOL; MUTATION; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 84892500332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084220     Document Type: Article

References (51)

1. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. doi:10.1128/CMR.15.2.167-193.2002. PubMed: 11932229.
2. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56. doi:10.1038/nrmicro1557. PubMed: 17143318.
3. Orman MA, Brynildsen MP (2013) Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57: 3230-3239. doi:10.1128/AAC.00243-13. PubMed: 23629720.
4. Dawson CC, Intapa C, Jabra-Rizk MA (2011) "Persisters": survival at the cellular level. PLOS Pathog 7: e1002121.
5. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230: 13-18. doi:10.1016/S0378-1097(03)00856-5. PubMed: 14734160.
6. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2: e00100-e00111. PubMed: 21673191.
7. Vogt SL, Green C, Stevens KM, Day B, Erickson DL et al. (2011) The stringent response is essential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infection. Infect Immun 79: 4094-4104. doi:10.1128/IAI.00193-11. PubMed: 21788391.
8. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O et al. (2011) Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334: 982-986. doi:10.1126/science.1211037. PubMed: 22096200.
9. McCollister BD, Hoffman M, Husain M, Vázquez-Torres A (2011) Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake. Antimicrob Agents Chemother 55: 2189-2196. doi:10.1128/AAC.01203-10. PubMed: 21343448.
10. Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G et al. (2013) Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet 9: e1003144. PubMed: 23300476.
11. Amato SM, Orman MA, Brynildsen MP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50: 475-487. doi:10.1016/j.molcel.2013. 04.002. PubMed: 23665232.
12. Klapper I, Gilbert P, Ayati BP, Dockery J, Stewart PS (2007) Senescence can explain microbial persistence. Microbiology 153: 3623-3630. doi:10.1099/mic.0.2007/006734-0. PubMed: 17975070.
13. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372. doi:10.1146/annurev.micro.112408.134306. PubMed: 20528688.
14. Wang X, Wood TK (2011) Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol 77: 5577-5583. doi:10.1128/AEM.05068-11. PubMed: 21685157.
15. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T (2008) Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68: 223-240. doi:10.1111/j.1365-2958.2008.06152.x. PubMed: 18312276.
16. Herrmann G, Yang L, Wu H, Song Z, Wang H et al. (2010) Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis 202: 1585-1592. doi:10.1086/656788. PubMed: 20942647.
17. Falagas ME, Rafailidis PI (2009) Nephrotoxicity of colistin: new insight into an old antibiotic. Clin Infect Dis 48: 1729-1731. doi:10.1086/599226. PubMed: 19438398.
18. Moreau-Marquis S, O'Toole GA, Stanton BA (2009) Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 41: 305-313. doi:10.1165/rcmb.2008- 0299OC. PubMed: 19168700.
19. Yu Q, Griffin EF, Moreau-Marquis S, Schwartzman JD, Stanton BA et al. (2012) In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. J Antimicrob Chemother 67: 2673-2681. doi:10.1093/jac/dks296. PubMed: 22843834.
20. Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M et al. (2009) Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 34: 370-374. doi:10.1016/j.ijantimicag.2009.04.010. PubMed: 19505804.
21. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220. doi:10.1038/nature10069. PubMed: 21562562.
22. Daviskas E, Anderson SD, Eberl S, Chan HK, Bautovich G (1999) Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med 159: 1843-1848. doi:10.1164/ajrccm. 159.6.9809074. PubMed: 10351929.
23. Daviskas E, Anderson SD, Jaques A, Charlton B (2010) Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest 137: 861-868. doi:10.1378/chest.09-2017. PubMed: 19880909.
24. Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363: 2233-2247. doi:10.1056/NEJMra0910061. PubMed: 21121836.
25. Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J et al. (2011) Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study. Eur Respir J 38: 1071-1080. doi:10.1183/09031936.00187510. PubMed: 21478216.
26. Bilton D, Bellon G, Charlton B, Cooper P, De Boeck K et al. (2013) Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. J Cyst Fibros 12: 367-376. doi:10.1016/j.jcf.2012.11.002. PubMed: 23234802.
27. Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 479-487. doi:10.1128/AAC.49.2.479-487.2005. PubMed: 15673721.
28. Holloway BW (1955) Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13: 572-581. doi:10.1099/00221287-13-3-572. PubMed: 13278508.
29. Ohman DE, Chakrabarty AM (1981) Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. Infect Immun 33: 142-148. PubMed: 6790439.
30. O'May CY, Reid DW, Kirov SM (2006) Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol 48: 373-380. doi:10.1111/j.1574- 695X.2006.00157.x. PubMed: 17052266.
31. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E et al. (2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 14339-14344. doi:10.1073/pnas.2036282100. PubMed: 14617778.
32. Yepuri NR, Barraud N, Shah Mohammadi N, Kardak BG, Kjelleberg S et al. (2013) Synthesis of cephalosporin-3'-diazeniumdiolates: biofilm dispersing NO-donor prodrugs activated by beta-lactamase. Chem Commun 49: 4791-4793. doi:10.1039/c3cc40869h.
33. Hoben HJ, Somasegaran P (1982) Comparison of the pour, spread, and drop plate methods for enumeration of Rhizobium spp. in inoculants made from presterilized peat. Appl Environ Microbiol 44: 1246-1247. PubMed: 16346141.
34. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK et al. (2007) Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357: 654-663. doi:10.1056/NEJMoa061588. PubMed: 17699815.
35. Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192: 6191-6199. doi:10.1128/JB.01651-09. PubMed: 20935098.
36. Barraud N, Kardak BG, Yepuri NR, Howlin RP, Webb JS et al. (2012) Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms. Angew Chem Int Ed Engl 51: 9057-9060. doi:10.1002/anie. 201202414. PubMed: 22890975.
37. Schleheck D, Barraud N, Klebensberger J, Webb JS, McDougald D et al. (2009) Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLOS ONE 4: e5513. doi:10.1371/journal.pone.0005513. PubMed: 19436737.
38. Sauer K, Cullen MC, Rickard AH, Zeef LA, Davies DG et al. (2004) Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bacteriol 186: 7312-7326. doi:10.1128/JB.186.21.7312-7326.2004. PubMed: 15489443.
39. Barraud N, Storey MV, Moore ZP, Webb JS, Rice SA et al. (2009) Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms. Microb Biotechnol 2: 370-378. doi:10.1111/j.1751-7915.2009.00098.x. PubMed: 21261931.
40. Sternberg C, Christensen BB, Johansen T, Toftgaard Nielsen A, Andersen JB et al. (1999) Distribution of bacterial growth activity in flow-chamber biofilms. Appl Environ Microbiol 65: 4108-4117. PubMed: 10473423.
41. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A et al. (2004) Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 70: 6188-6196. doi:10.1128/AEM.70.10.6188-6196.2004. PubMed: 15466566.
42. Hentzer M, Eberl L, Givskov M (2005) Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2: 37-61. doi:10.1017/S1479050505001699.
43. Dörr T, Vuliæ M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8: e1000317. PubMed: 20186264.
44. Elliott D, Burns JL, Hoffman LR (2010) Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 54: 3024-3026. doi:10.1128/AAC.00102-10. PubMed: 20404125.
45. Leszczynska D, Matuszewska E, Kuczynska-Wisnik D, Furmanek-Blaszk B, Laskowska E (2013) The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins. PLOS ONE 8: e54737. doi:10.1371/journal.pone.0054737. PubMed: 23358116.
46. Albesa I, Becerra MC, Battán PC, Páez PL (2004) Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 317: 605-609. doi:10.1016/j.bbrc.2004.03.085. PubMed: 15063800.
47. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens- Habbena W et al. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712. PubMed: 20072604.
48. Jennings DB, Ehrenshaft M, Pharr DM, Williamson JD (1998) Roles for mannitol and mannitol dehydrogenase in active oxygen-mediated plant defense. Proc Natl Acad Sci U S A 95: 15129-15133. doi:10.1073/pnas.95.25.15129. PubMed: 9844027.
49. Pan J, Bahar AA, Syed H, Ren D (2012) Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3- methylfuran-2(5H)-one. PLOS ONE 7: e45778. doi:10.1371/journal.pone.0045778. PubMed: 23029239.
50. Kim JS, Heo P, Yang TJ, Lee KS, Cho DH et al. (2011) Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother 55: 5380-5383. doi:10.1128/AAC.00708-11. PubMed: 21844322.
51. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS et al. (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59: 1114-1128. doi:10.1111/j.1365-2958.2005.05008.x. PubMed: 16430688.